What is an enteric fistula and could green drainage from a Jackson‑Pratt drain after ventral or incisional hernia repair with mesh indicate its presence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is an Enteric Fistula and Its Relevance to Green Drainage After Hernia Repair

An enteric fistula is an abnormal communication between the intestinal tract and another structure—either another organ, the skin (enterocutaneous), or the atmosphere—and green drainage from a Jackson-Pratt drain after ventral or incisional hernia repair with mesh strongly suggests this serious complication, particularly an enterocutaneous fistula. 1, 2

Definition and Types

An enteric fistula represents any pathological connection originating from the bowel. 2 The most relevant types in the context of hernia repair include:

  • Enterocutaneous fistula: Communication between bowel and skin or external atmosphere, which is the most likely diagnosis when green (bilious or enteric) drainage appears in a surgical drain 1, 2
  • Enteroenteric fistula: Connection between bowel segments, often asymptomatic 1
  • Enterovesical fistula: Connection to the bladder 1

Clinical Significance of Green Drainage Post-Hernia Repair

Green drainage from a Jackson-Pratt drain after ventral or incisional hernia repair with mesh placement is highly suspicious for an enterocutaneous fistula and represents a surgical emergency requiring immediate evaluation. 3, 4, 5

The green color indicates enteric content (bile, succus entericus, or intestinal secretions) communicating with the surgical site. 2 This complication, while rare, is serious and can occur:

  • Early: Within days to weeks postoperatively due to unrecognized bowel injury, inadequate source control, or technical complications 1, 2
  • Late: Months to years after repair (reported cases at 6-10 years) due to mesh erosion into bowel 3, 4, 5

Pathophysiology in Mesh-Related Hernias

Mesh-related enterocutaneous fistulas develop through several mechanisms:

  • Direct mesh-bowel contact: Synthetic mesh placed intraperitoneally or in direct contact with bowel loops can erode into the intestinal lumen over time 3, 4, 5
  • Mesh migration: Gradual displacement of mesh toward and into adjacent bowel 4
  • Chronic inflammation and adhesions: Leading to pressure necrosis and eventual perforation 3, 5
  • Infection: Mesh infection can progress to involve adjacent bowel, creating fistulous communication 1, 3

Immediate Diagnostic and Management Algorithm

Step 1: Confirm Enteric Content

  • Analyze drain fluid: Green/bilious appearance, elevated bilirubin, or presence of enteric enzymes confirms intestinal origin 2
  • Assess drain output volume: High-output fistulas (>500 mL/day) indicate more proximal bowel involvement and greater nutritional risk 1, 2

Step 2: Rule Out Sepsis and Abscess

  • Evaluate for systemic inflammatory response: Fever, tachycardia, leukocytosis suggest associated intra-abdominal abscess requiring urgent drainage 1
  • Obtain CT imaging with contrast: Essential to identify abscess collections, define fistula anatomy, assess for bowel obstruction, and evaluate mesh position 1, 2
  • Drain any identified collections: Radiological or surgical drainage is mandatory before definitive management 1

Step 3: Optimize Patient Status (Sepsis-Nutrition-Anatomy Framework)

The management of enterocutaneous fistula requires addressing three key factors:

  • Control sepsis: Aggressive drainage of abscesses, appropriate antimicrobials, and source control 1, 2
  • Optimize nutrition: High-output fistulas cause massive protein and electrolyte losses; enteral feeding is preferred when tolerated, otherwise parenteral nutrition is essential 1, 2
  • Define anatomy: Fistulography or CT fistulography to map the tract, identify distal obstruction, and plan surgical approach 1, 2

Step 4: Definitive Management Strategy

Complete mesh excision with bowel resection and repair is required for mesh-related enterocutaneous fistulas, as partial mesh removal results in 29% fistula recurrence versus 6% with complete excision. 6

  • Timing: Definitive surgery should be delayed 3-6 months after initial presentation to allow inflammation to resolve, nutritional optimization, and wound healing 1, 2
  • Surgical approach: Requires complete excision of involved mesh, resection of fistulous bowel segment, and primary anastomosis 1, 6
  • Hernia repair: Simultaneous ventral hernia repair with non-bridged biological mesh (acellular porcine dermal matrix) results in 26% recurrence versus 66% with suture repair alone 6
  • Avoid synthetic mesh: In contaminated fields with bowel resection, biological mesh or primary repair is preferred 1, 6

Critical Pitfalls to Avoid

  • Do not attempt conservative management: Mesh-related enterocutaneous fistulas do not close spontaneously and require surgical intervention 6
  • Do not perform partial mesh excision: Leaving any mesh in contact with the fistula tract increases recurrence risk nearly 5-fold 6
  • Do not rush to surgery: Premature operation before nutritional optimization and sepsis control leads to failure and increased mortality 1, 2
  • Do not ignore associated complications: Luminal strictures, multiple fistula tracts, and frozen abdomen significantly complicate management and must be identified preoperatively 1

Prevention Strategies

To minimize risk of enterocutaneous fistula in hernia repair:

  • Avoid direct mesh-bowel contact: Use preperitoneal or retrorectus mesh placement rather than intraperitoneal onlay 4, 5
  • Cover exposed bowel: Use omentum, peritoneum, or barrier materials when intraperitoneal mesh is necessary 1
  • Ensure adequate bowel coverage: Deep burying of intestinal anastomoses under bowel loops prevents direct mesh contact 1
  • Recognize high-risk scenarios: Emergency repair, contaminated fields, bowel resection, and poor tissue quality increase fistula risk 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of Enterocutaneous Fistula: A Review.

JNMA; journal of the Nepal Medical Association, 2022

Research

Late intestinal fistula formation after incisional hernia using intraperitoneal mesh.

Hernia : the journal of hernias and abdominal wall surgery, 2005

Related Questions

What is the appropriate workup and management for an adult patient with an umbilical hernia and an enterocutaneous fistula, potentially having underlying conditions such as diabetes or obesity?
What is the management for a patient with an enterocutaneous fistula (abnormal connection between the intestine and skin) experiencing blood clots in the ostomy (surgical creation of an opening in the body) bag?
How to manage a colocutaneous fistula secondary to malignancy?
What is the best course of action for a patient suspected of having an entero-uterine fistula due to air in the endometrial cavity?
How can enterocutaneous fistula be prevented?
Is the inpatient and outpatient diabetes management guideline you provided based on the latest American Diabetes Association Standards of Care (2024/2025)?
How should I reconstitute 36 mg of Retatrutide to achieve a concentration of 12 mg/mL?
What is the recommended management for chronic fatigue syndrome (myalgic encephalomyelitis)?
In a 40‑year‑old male with major depressive disorder, generalized anxiety disorder, adjustment disorder, attention‑deficit/hyperactivity disorder, chronic nicotine and marijuana use, hypertension, benign prostatic hyperplasia, obstructive sleep apnea (adherent to CPAP), and shift‑work sleep disorder, currently on escitalopram 10 mg daily, propranolol 120 mg extended‑release, tamsulosin 0.4 mg, and recently started Adderall (amphetamine‑dextroamphetamine) XR 10 mg, who refuses any medication changes despite fatigue on dose increase, reports irritability, occasional spending sprees, and a positive Mood Disorder Questionnaire but does not meet full DSM‑5 bipolar criteria, how can I further evaluate for bipolar disorder and what management steps are appropriate given his medication refusal and functional impairment?
When and how should antiplatelet therapy be initiated after a massive ischemic stroke once intracranial hemorrhage has been excluded?
How should coronary artery disease be managed, including risk‑factor modification, medication therapy, and revascularization?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.